SILTUXIMAB

siltuximab 100 mg injection, 1 vial

SILTUXIMAB (12930M)

siltuximab 100 mg injection, 1 vial
12930M
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Idiopathic multicentric Castleman disease (iMCD)
Treatment phase: Initial treatment

Restriction

Indication: Idiopathic multicentric Castleman disease (iMCD)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 4 DPMQ: $1,607.44 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Sylvant